Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: A randomized controlled trial

JAMA

Volumn 287, Issue 24, 2002, Pages 3215-3222

  Serruys, Patrick W J C ^a   De Feyter, Pim ^a   Macaya, Carlos ^b   Kokott, Norbert ^j   Puel, Jacques ^c   Vrolix, Matthias ^d   Branzi, Angelo ^e   Bertolami, Marcelo C ^f   Jackson, Graham ^g   Strauss, Bradley ^h   Meier, Bernhard ⁱ  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c CHU PURPAN   (France)

^d St Jan Hospital   (Belgium)

^e UNIVERSITY OF BOLOGNA   (Italy)

^f INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^g GUY S HOSPITAL   (United Kingdom)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ UNIVERSITY OF BERN   (Switzerland)

^j Koepenick Hospital   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATINE KINASE; FLUINDOSTATIN; TRIACYLGLYCEROL;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART DISEASE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; SURVIVAL; TREATMENT OUTCOME; TREATMENT PLANNING; TRIACYLGLYCEROL BLOOD LEVEL; UNSTABLE ANGINA PECTORIS;

EID: 0037178569     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.24.3215     Document Type: Article

References (25)

1. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery
2. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease
3. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients
4. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
5. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
6. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
7. The MRC/BHF Heart Protection Study: Preliminary results
8. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty
9. Lack of effect of lovastatin on restenosis after coronary angioplasty
10. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: Final results of the Fluvastatin Angiographic Restenosis (FLARE) trial
11. Influence of serum cholesterol and cholesterol subfraction on restenosis after successful coronary angioplasty: A quantitative angiographic analysis of 3336 lesions
12. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention
13. The Lescol Intervention Prevention Study (LIPS): A double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease
14. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations
15. Diabetes and glucose tolerance as risk factors for cardiovascular disease: The Framingham Study
16. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
17. Influence of baseline lipids on effectiveness of pravastatin in the CARE trial
18. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
19. One-year results of the Thrombolysis in Myocardial Infraction (TIMI) IIIB clinical trial: A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction
20. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
21. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study
22. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
23. Sustained suppression of neointimal proliferation by sirolimuseluting stents: One-year angiographic and intravascular ultrasound follow-up
24. Coronary restenosis elimination with a sirolimus eluting stent: First European human experience with 6-month angiographic and ultrasonic follow-up